688410 山外山
已收盘 08-13 15:00:00
资讯
新帖
简况
山外山(688410)披露大股东减持股份计划公告,8月12日股价下跌0.45%
证券之星 · 08-12 22:28
山外山(688410)披露大股东减持股份计划公告,8月12日股价下跌0.45%
山外山(688410.SH):大股东拟减持不超4.03%股份
智通财经 · 08-12 16:23
山外山(688410.SH):大股东拟减持不超4.03%股份
山外山新注册《山外山CRM-小程序V2.0》项目的软件著作权
证券之星 · 08-12 02:27
山外山新注册《山外山CRM-小程序V2.0》项目的软件著作权
股市必读:山外山(688410)8月6日董秘有最新回复
证券之星 · 08-07
股市必读:山外山(688410)8月6日董秘有最新回复
每周股票复盘:山外山(688410)股东户数增1.83%,户均持股市值42.84万
证券之星 · 08-02
每周股票复盘:山外山(688410)股东户数增1.83%,户均持股市值42.84万
山外山(688410)7月20日股东户数1.08万户,较上期增加1.83%
证券之星 · 07-29
山外山(688410)7月20日股东户数1.08万户,较上期增加1.83%
山外山:截至2026年7月20日,山外山公司的股东户数为10,800户
证券之星 · 07-29
山外山:截至2026年7月20日,山外山公司的股东户数为10,800户
7月28日山外山涨6.02%,鹏华医药科技股票A基金重仓该股
证券之星 · 07-28
7月28日山外山涨6.02%,鹏华医药科技股票A基金重仓该股
山外山涨6.02%,中邮证券二个月前给出“买入”评级
证券之星 · 07-28
山外山涨6.02%,中邮证券二个月前给出“买入”评级
山外山获得实用新型专利授权:“一种透析浓缩液配制装置”
证券之星 · 07-24
山外山获得实用新型专利授权:“一种透析浓缩液配制装置”
山外山最新公告:全资子公司取得一次性使用血液透析管路医疗器械注册证
证券之星 · 07-22
山外山最新公告:全资子公司取得一次性使用血液透析管路医疗器械注册证
每周股票复盘:山外山(688410)股东户数降至1.06万
证券之星 · 07-19
每周股票复盘:山外山(688410)股东户数降至1.06万
山外山(688410)披露作废2023年限制性股票激励计划部分限制性股票公告,7月16日股价下跌1.9%
证券之星 · 07-16
山外山(688410)披露作废2023年限制性股票激励计划部分限制性股票公告,7月16日股价下跌1.9%
山外山新注册《山外山SWS-7000系列主控软件V7.0》项目的软件著作权
证券之星 · 07-15
山外山新注册《山外山SWS-7000系列主控软件V7.0》项目的软件著作权
股市必读:山外山(688410)股东户数1.06万户,较上期减少1.81%
证券之星 · 07-15
股市必读:山外山(688410)股东户数1.06万户,较上期减少1.81%
山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权
证券之星 · 07-10
山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权
每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股
证券之星 · 07-05
每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股
山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%
证券之星 · 07-03
山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%
股市必读:山外山(688410)6月30日董秘有最新回复
证券之星 · 07-01
股市必读:山外山(688410)6月30日董秘有最新回复
山外山涨6.82%,中邮证券一个月前给出“买入”评级
证券之星 · 06-29
山外山涨6.82%,中邮证券一个月前给出“买入”评级
加载更多
公司概况
公司名称:
重庆山外山血液净化技术股份有限公司
所属行业:
专用设备制造业
上市日期:
2022-12-26
主营业务:
重庆山外山血液净化技术股份有限公司的主营业务是血液净化设备与耗材的研发、生产和销售,并提供连锁血液透析医疗服务。公司的主要产品是血液灌流机、连续性血液净化设备、血液透析机、血液净化设备、血液透析浓缩液、血液透析干粉、血液透析器、透析液过滤器、连续性血液净化管路、一次性使用血液灌流器。公司形成了国家级企业技术中心、国家博士后科研工作站、国家地方联合工程研究中心等科技创新平台,先后荣获“国家科学技术进步奖二等奖”等多项国家级奖项,被评为“国家技术创新示范企业”。
发行价格:
32.30
{"stockData":{"symbol":"688410","market":"SH","secType":"STK","nameCN":"山外山","latestPrice":11.4,"timestamp":1786604400000,"preClose":11.11,"halted":0,"volume":24091457,"delay":0,"changeRate":0.0261,"floatShares":447000000,"shares":447000000,"eps":0.3651,"marketStatus":"已收盘","change":0.29,"latestTime":"08-13 15:00:00","open":10.93,"high":11.65,"low":10.63,"amount":269000000,"amplitude":0.0918,"askPrice":11.4,"askSize":249,"bidPrice":11.39,"bidSize":320,"shortable":0,"etf":0,"ttmEps":0.3651,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":5,"adr":0,"adjPreClose":11.11,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":12.22,"lowLimit":10,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447440870,"isCdr":false,"pbRate":2.78,"roa":"--","peRate":31.224322,"roe":"3.02%","epsLYR":0.4589,"committee":-0.255358,"marketValue":5101000000,"turnoverRate":0.0538,"status":0,"afterMarket":{"amount":0,"volume":0,"close":11.4,"buyVolume":0,"sellVolume":0,"time":1786606437746,"indexStatus":"已收盘 08-13 15:30:00","preClose":11.11},"floatMarketCap":5101000000},"requestUrl":"/m/hq/s/688410","defaultTab":"news","newsList":[{"id":"2658590537","title":"山外山(688410)披露大股东减持股份计划公告,8月12日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658590537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658590537?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:28","pubTimestamp":1786544897,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘,山外山报收于11.11元,较前一交易日下跌0.45%,最新总市值为49.71亿元。该股当日开盘11.19元,最高11.34元,最低11.05元,成交额达6698.3万元,换手率为1.34%。近日,山外山披露《股东减持股份计划公告》。截至公告披露日,大股东湖南湘江大健康创业投资合伙企业持有山外山8.79%股份,其一致行动人合计持股9.00%。本次减持计划符合相关法律法规规定,不存在导致控制权变更的风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200040256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927738","title":"山外山(688410.SH):大股东拟减持不超4.03%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927738","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658927738?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:23","pubTimestamp":1786522990,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山外山(688410.SH)发布公告,公司大股东湖南湘江力远投资管理有限公司-湖南湘江大健康创业投资合伙企业(有限合伙)因自身资金需求,拟通过大宗交易的方式减持其所持有的公司股份不超过1803.19万股,此次减持比例不超过公司总股本的4.03%,自减持计划公告之日起15个交易日后的3个月内(2026年9月3日至2026年12月2日)实施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478944.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658172709","title":"山外山新注册《山外山CRM-小程序V2.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2658172709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658172709?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:27","pubTimestamp":1786472831,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山(688410)新注册了《山外山CRM-小程序V2.0》项目的软件著作权。今年以来山外山新注册软件著作权8个,较去年同期增加了14.29%。结合公司2025年年报财务数据,2025年公司在研发方面投入了6278.49万元,同比增15.75%。通过天眼查大数据分析,重庆山外山血液净化技术股份有限公司共对外投资了8家企业,参与招投标项目1282次;财产线索方面有商标信息139条,专利信息271条,著作权信息63条;此外企业还拥有行政许可60个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","159180","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657165156","title":"股市必读:山外山(688410)8月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657165156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657165156?lang=zh_cn&edition=full","pubTime":"2026-08-07 02:01","pubTimestamp":1786039279,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘,山外山报收于11.08元,下跌1.07%,换手率1.54%,成交量6.9万手,成交额7695.96万元。董秘最新回复投资者: 董秘您好!咨询问题:1.2023年公司毛利率是54.07%,而2024年公司毛利率降至45.29%,能详细说说原有吗?董秘: 尊敬的投资者您好,山外山公司2024年综合毛利率为45.29%,较上年同期下降原因主要系产品结构变动所致。当日关注点交易信息汇总:8月6日主力资金净流出227.76万元,占总成交额2.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700001901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656316453","title":"每周股票复盘:山外山(688410)股东户数增1.83%,户均持股市值42.84万","url":"https://stock-news.laohu8.com/highlight/detail?id=2656316453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656316453?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:16","pubTimestamp":1785608173,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,山外山报收于10.59元,较上周的9.4元上涨12.66%。本周,山外山7月29日盘中最高价报10.96元。山外山当前最新总市值47.38亿元,在医疗器械板块市值排名69/129,在两市A股市值排名3111/5202。户均持股数量由上期的3.01万股增加至4.14万股,户均持股市值为42.84万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655865803","title":"山外山(688410)7月20日股东户数1.08万户,较上期增加1.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655865803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655865803?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:37","pubTimestamp":1785317860,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山披露,截至2026年7月20日公司股东户数为1.08万户,较6月30日增加194.0户,增幅为1.83%。在医疗器械行业个股中,山外山股东户数低于行业平均水平,截至7月20日,医疗器械行业平均股东户数为2.14万户。从股价来看,2026年6月30日至2026年7月20日,山外山区间涨幅为2.19%,在此期间股东户数增加194.0户,增幅为1.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655522248","title":"山外山:截至2026年7月20日,山外山公司的股东户数为10,800户","url":"https://stock-news.laohu8.com/highlight/detail?id=2655522248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655522248?lang=zh_cn&edition=full","pubTime":"2026-07-29 15:33","pubTimestamp":1785310431,"startTime":"0","endTime":"0","summary":"证券之星消息,山外山(688410)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问:您好:请问最新一期股东人数山外山回复:尊敬的投资者您好,截至2026年7月20日,山外山公司的股东户数为10,800户。感谢您对公司的关注。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900020610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654775330","title":"7月28日山外山涨6.02%,鹏华医药科技股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654775330","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654775330?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:45","pubTimestamp":1785228357,"startTime":"0","endTime":"0","summary":"证券之星消息,7月28日山外山涨6.02%,收盘报10.22元,换手率3.35%,成交量15.0万手,成交额1.52亿元。重仓山外山的公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级5家。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共8家,其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800026810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410","BK1515","159938","BK1161","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654207731","title":"山外山涨6.02%,中邮证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2654207731","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654207731?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:45","pubTimestamp":1785228348,"startTime":"0","endTime":"0","summary":"今日山外山(688410)涨6.02%,收盘报10.22元。2026年5月8日,中邮证券研究员盛丽华发布了对山外山的研报《业绩持续高增,设备与耗材双轮驱动盈利向上》,该研报对山外山给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为77.13%。此外,太平洋研究员谭紫媚,李啸岩,信达证券研究员唐爱金近期也对该股发布了研报,同样给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为东北证券的文将儒、叶菁。山外山(688410)个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800026808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653778989","title":"山外山获得实用新型专利授权:“一种透析浓缩液配制装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653778989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653778989?lang=zh_cn&edition=full","pubTime":"2026-07-24 03:32","pubTimestamp":1784835123,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示山外山新获得一项实用新型专利授权,专利名为“一种透析浓缩液配制装置”,专利申请号为CN202520827657.9,授权日为2026年7月24日。通过天眼查大数据分析,重庆山外山血液净化技术股份有限公司共对外投资了8家企业,参与招投标项目1258次;财产线索方面有商标信息139条,专利信息270条,著作权信息63条;此外企业还拥有行政许可60个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400003574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653777756","title":"山外山最新公告:全资子公司取得一次性使用血液透析管路医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2653777756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653777756?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:55","pubTimestamp":1784714121,"startTime":"0","endTime":"0","summary":"山外山(688410.SH)公告称,公司全资子公司重庆天外天生物技术有限公司近日收到国家药监局颁发的《医疗器械注册证》,产品为“一次性使用血液透析管路”,适用于血液透析、血液滤过、血液透析滤过、血液透析联合灌流治疗时建立体外循环通道。该注册证为首次注册,有效期至2031年7月19日。公司表示,该产品将拓展血液净化耗材产品线,完善产品矩阵,提升市场竞争力。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200037106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159883","BK1583","BK1100","09996","688410","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652623709","title":"每周股票复盘:山外山(688410)股东户数降至1.06万","url":"https://stock-news.laohu8.com/highlight/detail?id=2652623709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652623709?lang=zh_cn&edition=full","pubTime":"2026-07-19 01:59","pubTimestamp":1784397548,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,山外山报收于10.44元,较上周的10.3元上涨1.36%。本周,山外山7月15日盘中最高价报11.95元。公司公告汇总:山外山首次授予第一个归属期归属条件成就,170名激励对象可归属122.7368万股。公司公告汇总:因离职及业绩考核未达标,山外山作废限制性股票合计1,984.6167万股。股本股东变化股东户数变动截至2026年6月30日,山外山股东户数为1.06万户,较6月18日减少196.0户,减幅为1.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428534","title":"山外山(688410)披露作废2023年限制性股票激励计划部分限制性股票公告,7月16日股价下跌1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428534","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651428534?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:29","pubTimestamp":1784212151,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘,山外山报收于11.37元,较前一交易日下跌1.9%,最新总市值为50.87亿元。公司于2026年7月16日召开第四届董事会第二次会议,审议通过了关于作废2023年限制性股票激励计划部分限制性股票的议案。由于35名激励对象离职,以及公司2024年、2025年业绩考核未达标,导致部分限制性股票无法归属。本次合计作废限制性股票1,984.6167万股,其中因离职作废298.3813万股,因考核未达标作废1,686.2354万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651483258","title":"山外山新注册《山外山SWS-7000系列主控软件V7.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2651483258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651483258?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:08","pubTimestamp":1784052496,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山(688410)新注册了《山外山SWS-7000系列主控软件V7.0》项目的软件著作权。今年以来山外山新注册软件著作权7个,较去年同期增加了16.67%。结合公司2025年年报财务数据,2025年公司在研发方面投入了6278.49万元,同比增15.75%。通过天眼查大数据分析,重庆山外山血液净化技术股份有限公司共对外投资了8家企业,参与招投标项目1255次;财产线索方面有商标信息139条,专利信息269条,著作权信息60条;此外企业还拥有行政许可60个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651488091","title":"股市必读:山外山(688410)股东户数1.06万户,较上期减少1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651488091","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651488091?lang=zh_cn&edition=full","pubTime":"2026-07-15 01:24","pubTimestamp":1784049851,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘,山外山报收于11.64元,上涨8.18%,换手率4.25%,成交量19.02万手,成交额2.16亿元。交易信息汇总资金流向7月14日主力资金净流入1382.73万元,占总成交额0.0%;游资资金净流出243.57万元,占总成交额0.0%;散户资金净流出1139.16万元,占总成交额0.0%。股本股东变化股东户数变动截至2026年6月30日公司股东户数为1.06万户,较6月18日减少196.0户,减幅为1.81%。户均持股数量由上期的2.96万股增加至3.01万股,户均持股市值为43.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500001866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650979664","title":"山外山新注册《山外山客服管理系统V2.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2650979664","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650979664?lang=zh_cn&edition=full","pubTime":"2026-07-10 02:21","pubTimestamp":1783621269,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山外山(688410)新注册了2个项目的软件著作权,包括《山外山客服管理系统V2.0》、《山外山SWS-4000系列主控软件V4.11》等。今年以来山外山新注册软件著作权6个。结合公司2025年年报财务数据,2025年公司在研发方面投入了6278.49万元,同比增15.75%。通过天眼查大数据分析,重庆山外山血液净化技术股份有限公司共对外投资了8家企业,参与招投标项目1250次;财产线索方面有商标信息139条,专利信息269条,著作权信息60条;此外企业还拥有行政许可60个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649928086","title":"每周股票复盘:山外山(688410)拟每股派现0.20元及转增0.4股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649928086","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649928086?lang=zh_cn&edition=full","pubTime":"2026-07-05 03:19","pubTimestamp":1783192750,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,山外山报收于15.55元,较上周的13.64元上涨14.0%。本周,山外山7月3日盘中最高价报15.88元。山外山当前最新总市值49.7亿元,在医疗器械板块市值排名68/129,在两市A股市值排名3234/5203。本周关注点公司公告汇总:山外山拟每股派发现金红利0.20元(含税),同时每股转增0.4股。公司公告汇总:本次权益分派后,山外山总股本将增至447,440,870股。公司公告汇总:山外山股权登记日为2026年7月9日,除权除息日为2026年7月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648966129","title":"山外山(688410)披露2025年年度权益分派实施公告,7月3日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648966129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648966129?lang=zh_cn&edition=full","pubTime":"2026-07-03 22:39","pubTimestamp":1783089558,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,山外山报收于15.55元,较前一交易日上涨0.84%,最新总市值为49.7亿元。该股当日开盘15.41元,最高15.88元,最低15.34元,成交额达9842万元,换手率为1.98%。近日,重庆山外山血液净化技术股份有限公司发布2025年年度权益分派实施公告:每股派发现金红利0.20元(含税),每股转增0.4股。本次权益分派以公司总股本319,600,622股为基数,共计派发现金红利63,920,124.40元,转增127,840,248股,转增后总股本为447,440,870股。公司首发战略配售股份已全部上市流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300045974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648598598","title":"股市必读:山外山(688410)6月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648598598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648598598?lang=zh_cn&edition=full","pubTime":"2026-07-01 06:40","pubTimestamp":1782859256,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,山外山报收于14.36元,下跌1.44%,换手率1.81%,成交量5.78万手,成交额8338.07万元。根据公司已披露的2025年年度报告,公司2025年实现营业总收入80,690.78万元,同比增长42.24%;实现归属于上市公司股东的净利润14,588.55万元,同比增长105.80%。2026年第一季度,公司实现营业收入22,962.89万元,同比增长21.33%,归属于上市公司股东的净利润5,447.67万元,同比增长47.21%,延续了良好的增长态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100008083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647223903","title":"山外山涨6.82%,中邮证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647223903","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647223903?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:39","pubTimestamp":1782722383,"startTime":"0","endTime":"0","summary":"今日山外山(688410)涨6.82%,收盘报14.57元。2026年5月8日,中邮证券研究员盛丽华发布了对山外山的研报《业绩持续高增,设备与耗材双轮驱动盈利向上》,该研报对山外山给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为77.13%。此外,太平洋研究员谭紫媚,李啸岩,信达证券研究员唐爱金近期也对该股发布了研报,同样给出“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为东北证券的文将儒、叶菁。山外山(688410)个股概况:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688410","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786644299199,"stockEarnings":[{"period":"1week","weight":0.0289},{"period":"1month","weight":-0.0206},{"period":"3month","weight":-0.0174},{"period":"6month","weight":-0.0623},{"period":"1year","weight":-0.0994},{"period":"ytd","weight":0.0811}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆山外山血液净化技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10800人(较上一季度增加1.83%)","perCapita":"41429股","listingDate":"2022-12-26","address":"重庆市两江新区慈济路1号","registeredCapital":"44744万元","survey":" 重庆山外山血液净化技术股份有限公司的主营业务是血液净化设备与耗材的研发、生产和销售,并提供连锁血液透析医疗服务。公司的主要产品是血液灌流机、连续性血液净化设备、血液透析机、血液净化设备、血液透析浓缩液、血液透析干粉、血液透析器、透析液过滤器、连续性血液净化管路、一次性使用血液灌流器。公司形成了国家级企业技术中心、国家博士后科研工作站、国家地方联合工程研究中心等科技创新平台,先后荣获“国家科学技术进步奖二等奖”等多项国家级奖项,被评为“国家技术创新示范企业”。","listedPrice":32.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山外山(688410)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山外山(688410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山外山,688410,山外山股票,山外山股票老虎,山外山股票老虎国际,山外山行情,山外山股票行情,山外山股价,山外山股市,山外山股票价格,山外山股票交易,山外山股票购买,山外山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山外山(688410)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山外山(688410)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}